Skip to main content
. 2023 Mar 22;31(7):1874–1903. doi: 10.1016/j.ymthe.2023.03.019

Figure 4.

Figure 4

Antibody, payload, and linker types

Types of antibody (A), payload (B), and linker (C) used in antibody-drug conjugates under development for patients with HER2-positive breast cancer in clinical trials. mAb, monoclonal antibody.